Skip to content

About Corsair Pharma
Transdermal Treprostinil
For Patients
News

About Corsair Pharma
Transdermal Treprostinil
For Patients
News

About Corsair Pharma
Transdermal Treprostinil
For Patients
News

About Corsair Pharma
Transdermal Treprostinil
For Patients
News

Events

No posts found

There is no Event

Disclaimer: TRX-248 is investigational and has not been approved by the U.S. Food and Drug Administration or any other regulatory authority.

© 2026 Corsair Phama, Inc.

Privacy Policy
Terms of Service
Cookie Preferences

Privacy Policy
Terms of Service
Cookie Preferences

Biotech Web Design